- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in the monitoring of direct oral anticoagulant therapy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 184, Issue 6, Pages 912-924
Publisher
Wiley
Online
2019-01-30
DOI
10.1111/bjh.15756
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial
- (2018) Ophelia Q. P. Yin et al. CIRCULATION
- 550
- (2018) Galit Frydman et al. CRITICAL CARE MEDICINE
- Screening test for direct oral anticoagulants with the dilute Russell viper venom time
- (2018) Jackie Pratt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
- (2018) S. Testa et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct-acting oral anticoagulant drug level monitoring in clinical patient management
- (2018) Amihai Rottenstreich et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2018) William J. Powers et al. STROKE
- International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
- (2018) Robert Gosselin et al. THROMBOSIS AND HAEMOSTASIS
- Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban
- (2018) Ashley E. Woodruff et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves
- (2018) Alberto Aimo et al. CIRCULATION
- Anti-Xa Activity and Event Risk in Patients With Direct Factor Xa Inhibitors Initiated Early After Stroke
- (2018) Shinichi Wada et al. CIRCULATION JOURNAL
- Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy
- (2018) Michelle Sholzberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Venous thromboembolism and women's health
- (2018) Victoria Speed et al. BRITISH JOURNAL OF HAEMATOLOGY
- Laboratory measurement of the direct oral anticoagulants: Indications and impact on management in clinical practice
- (2017) C. Wright et al. International Journal of Laboratory Hematology
- Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
- (2017) J. Douxfils et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Estimation of Rivaroxaban Plasma Concentrations in the Perioperative Setting in Patients With or Without Heparin Bridging
- (2016) Sarah Lessire et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
- (2016) K. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism
- (2016) Manuela Krause et al. THROMBOSIS RESEARCH
- Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics
- (2016) Sophie Testa et al. THROMBOSIS RESEARCH
- Laboratory measurement of the direct oral anticoagulants
- (2015) Brian J. Dale et al. BRITISH JOURNAL OF HAEMATOLOGY
- Are New Oral Anticoagulant Dosing Recommendations Optimal for All Patients?
- (2015) J. Robert Powell JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Point-of-Care Testing of Coagulation in Patients Treated With Non–Vitamin K Antagonist Oral Anticoagulants
- (2015) Matthias Ebner et al. STROKE
- Comparison of Methods to Determine Rivaroxaban anti-factor Xa activity
- (2015) Suman Rathbun et al. THROMBOSIS RESEARCH
- Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study
- (2015) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- New oral anticoagulants: dosing and monitoring
- (2015) J. P. Patel et al. BMJ-British Medical Journal
- New oral anticoagulants: dosing and monitoring
- (2015) J. P. Patel et al. BMJ-British Medical Journal
- Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation
- (2015) Iqbal H. Jaffer et al. Journal of the American Heart Association
- Comparison of Anti-Xa and Dilute Russell Viper Venom Time Assays in Quantifying Drug Levels in Patients on Therapeutic Doses of Rivaroxaban
- (2014) Robert C. Gosselin et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. BLOOD
- Normal prothrombin times in the presence of therapeutic levels of apixaban -in-vivoexperience from King's College Hospital
- (2014) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Measurement of non-Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology
- (2014) Steve Kitchen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Learning More From the Dabigatran Concentrations in the RE-LY Study
- (2014) Paul K.L. Chin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Measurement of the Direct Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Plasma Using Turbulent Flow Liquid Chromatography With High-Resolution Mass Spectrometry
- (2014) Tracey Gous et al. THERAPEUTIC DRUG MONITORING
- More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban - early experience from King's College Hospital
- (2013) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban
- (2013) Bernard Chatelain et al. THROMBOSIS AND HAEMOSTASIS
- Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology
- (2012) Trevor Baglin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bleeding Risk with Dabigatran in the Frail Elderly
- (2012) Paul Harper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature
- (2012) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- Anticoagulating obese patients in the modern era
- (2011) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Guidelines on oral anticoagulation with warfarin - fourth edition
- (2011) David Keeling et al. BRITISH JOURNAL OF HAEMATOLOGY
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
- (2009) Rianne MF van Schie et al. PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started